Fundació Hospital Universitari Vall dHebron - Institut de Recerca;Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca
发明人:
Simó Canonge, Rafael,Hernández Pascual, Cristina
申请号：
AU2017256803
公开号：
AU2017256803A1
申请日:
2017.04.28
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The invention relates to dipeptidyl peptidase-4 inhibitors, including saxagliptin and sitagliptin, for use in the topical eye treatment and/or prevention of retinal neurodegenerative diseases, in particulardiabetic retinopathyand its associated microvascular impairment. The invention also encompasses pharmaceutical topicaleyecompositions for use in the topicaltreatment and/or prevention of these diseases.
